Results 11 to 20 of about 4,276 (147)
Multiple myeloma with cardiac amyloidosis and secondary adrenal cortical dysfunction: a case report [PDF]
Multiple myeloma is a malignant proliferative disease of plasma cells, and some patients may develop systemic amyloidosis. Cardiac amyloidosis is a common cause of death in these patients.
CHEN Haifei, ZHOU Lingyun
core +1 more source
Research progress on osteoporotic vertebral collapse with delayed neurological deficits [PDF]
随着世界人口老龄化,骨质疏松已成为一项全球化的健康问题。骨折是骨质疏松最严重的后果,而骨质疏松性椎体骨折是最常见的骨折类型。骨质疏松性椎体骨折大; 多数可通过保守治疗获得骨折愈合,但仍有约10%~ 30%并发骨折不愈合,并渐进性出现骨质疏松性椎体骨折塌陷(osteoporotic; vertebral collapse,OVC); 其中约3% 的OVC伴有迟发性神经损害(delayed neurological; deficits,DND)。有关OVC并发DND的具体机制以及其治疗策略,文献报道不尽相同。
刘伯龄 +3 more
core +1 more source
Effects and mechanisms of Notch1 gene silencing by RNA interference on oncogenicity of human Multiple Myeloma Cells [PDF]
目的:通过RNA干扰技术,靶向沉默人多发性骨髓瘤RPMI8226细胞Notch1基因,评估Notch1表达下调后对多发性骨髓瘤细胞增殖、凋亡,相关蛋白Hes-1、Jagged-1、 Jagged-2及Bcl-2、PTEN/PI3K/AKT信号通路的影响,进一步探讨Notch1在多发性骨髓瘤发生发展中的作用及分子机制,为寻找新的骨髓瘤治疗靶点提供实验依据。 方法:构建靶向沉默Notch1基因的shRNA表达载体pGshRNA-Notch1,转染入人多发性骨髓瘤RPMI8226细胞,G418筛选稳定转染细胞。
陈美琼
core
Clinical pathway for diagnosis and treatment of new diagnosed multiple myeloma in Guangxi [PDF]
Multiple myeloma, an incurable clonal plasma cell dysplasia, is the second most common hematological malignancy. Standardized diagnosis and treatment are crucial for prolonging the survival of myeloma patients and improving the quality of their lives ...
Guangxi Plasma Cell Disease Collaboration +1 more
core +1 more source
多发性骨髓瘤(MM)是一种起源于骨髓的浆细胞恶性克隆增殖性疾病,好发于中老年人[1],发病率逐年增加,是血液系统较为常见恶性肿瘤。大多数患者随着近些年来免疫调节剂和蛋白酶体抑制剂的临床应用后总体生存率有显著提高,患者生存质量得以改善,然而难治性和复发性骨髓瘤患者的治疗效果不尽如人意。人CD38抗原为单链Ⅱ型跨膜糖蛋白,长度为45kDa,调节细胞活化、分化和增殖[2],通常在造血干细胞、T细胞、NK细胞和树突细胞中表达,外周血中性粒细胞和B淋巴细胞不表达,骨髓瘤细胞高量表达 ...
强新晨, 杨华莹, 邵俊良
doaj
shRNA targeting DNMT1 gene inhibit cell proliferation and reverse the methylation of tumor suppressor gene on Myeloma Cells [PDF]
摘要 探讨RNA干扰技术沉默DNA甲基化转移酶1(DNMT1)基因对骨髓瘤细胞増殖能力、凋亡以及相关基因甲基化水平的影响,为明确骨髓瘤发病的分子机制及开展去甲基化治疗提供实验依据. 方法: 构建靶向DNMT1基因的短发卡RNA(shRNA)真核表达载体,通过脂质体介导转染骨髓瘤RPMI8226细胞并经嘌呤霉素筛选出稳定转染株,同时分别设立(1)空白对照组:人多发性骨髓瘤细胞株RPMI8226及(2)阴性对照组:转染空载质粒shRNA的control-shRNA;RT ...
周雯雯
core
A case report of relapsed and refractory multiple myeloma with multifocal extramedullary infiltration and pulmonary adenocarcinoma [PDF]
Multiple myeloma (MM) remains an incurable disease, with most patients experiencing multiple relapses before ultimately progressing to refractory stage. Extramedullary infiltration is a common manifestation of relapse. However, distinguishing synchronous
CHEN Haifei +5 more
core +1 more source
目的探讨IgD型多发性骨髓瘤免疫分型中的特点及意义。方法用血清蛋白电泳法及免疫固定电泳法对70例IgD型多发性骨髓瘤进行分析及单扩散法定量检测。结果70例IgD型多发性骨髓瘤中IgDλ-型65例,IgDκ-型4例。本周蛋白阳性58例,本周λ型57例。具有IgDλ-;λ型双M成分28例。IgD重链型1例。结论IgD型多发性骨髓瘤免疫分型特征对IgD型多发性骨髓瘤的诊断及指导临床治疗具有重要意义。
翟玉华, 孙卫红, 刘金英
doaj
目的 探讨血清游离轻链比值(serum free light chain ratio,rFLC)测定对鉴别骨髓瘤肾病致尿毒症的指导意义。方法 采用免疫比浊法测定39例初诊为尿毒症患者的血清游离轻链值,根据其临床诊断分为多发性骨髓瘤致尿毒症组12例;非多发性骨髓瘤致尿毒症组27例;比较2组κ血清游离轻链(κ-sFLC)、λ血清游离轻链(λ-sFLC)及rFLC的差异,并分析其相关性。结果 多发性骨髓瘤致尿毒症患者κ-sFLC、λ-sFLC高于正常范围的比例分别为83.3%和66.6 ...
宋宁忆
doaj
未经治疗的CLL与MT2A-ELL融合突变的AML双重白血病1例
慢性淋巴细胞白血病(Chronic lymphocytic leukemia,CLL)是一种成熟的B细胞肿瘤,可引起患者的免疫抑制状态,增加其他类型癌症的发生率。根据以往研究,与一般人群相比,CLL患者同时发生恶性肿瘤(如肺癌、黑色素瘤等)的风险更高[1]。除了发展成实体瘤外,CLL患者易并发多发性骨髓瘤[2-3],骨髓增生异常综合征(MDS)和急性髓系白血病(AML)。然而,自20世纪70年代以来,只有数十例CLL并发其他血液系统恶性肿瘤的报道[4-8]。
张诗林 +4 more
doaj

